MedPath

ATIVAN

Approved
Approval ID

ba6ce50e-c5a9-47ca-9803-a1ed82172b0e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 8, 2011

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LORAZEPAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-813
Application NumberNDA017794
Product Classification
M
Marketing Category
C73594
G
Generic Name
LORAZEPAM
Product Specifications
Route of AdministrationORAL
Effective DateApril 13, 2009
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
LORAZEPAMActive
Quantity: 1 mg in 1 1
Code: O26FZP769L
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT

LORAZEPAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-937
Application NumberNDA017794
Product Classification
M
Marketing Category
C73594
G
Generic Name
LORAZEPAM
Product Specifications
Route of AdministrationORAL
Effective DateApril 13, 2009
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
LORAZEPAMActive
Quantity: 0.5 mg in 1 1
Code: O26FZP769L
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ATIVAN - FDA Drug Approval Details